1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMosaic Opioid Recovery Partnership is sponsored by RIZE Massachusetts Foundation. Provides funding to community-based organizations and municipalities in Massachusetts for initiatives addressing the opioid crisis, including prevention, treatment, and recovery services.
Get alerted about grants like this
Save a search for “RIZE Massachusetts Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Home - Mosaic - RIZE Massachusetts Funded by the MA Department of Public Health, Bureau of Substance Addiction Services and Powered by RIZE Massachusetts Foundation A Partnership Like No Other Municipalities Receive $1 . 25M in Matching Grants The second round of Mosaic Opioid Recovery Partnership’s Municipal Matching Grants program will provide $1 . 25 million in matching funds to 18 applicants representing 69 municipalities .
These investments will advance prevention , harm reduction , access to care , recovery , trauma and grief response , and family supports where they’re needed most . Mosaic Opioid Recovery Partnership (Mosaic), funded by the MA Department of Public Health, Bureau of Substance Addiction Services and powered by RIZE Massachusetts Foundation (RIZE), is a partnership like no other.
It is a unique, public-private collaboration designed to support initiatives that are addressing the opioid overdose crisis in communities that have been historically underserved and have experienced a high rate of opioid-related overdose deaths.
Just like a mosaic is made up of individual materials to create a complete picture, this partnership brings together the best ideas and initiatives across the Commonwealth to create a comprehensive response to the opioid overdose crisis.
The funding for Mosaic comes from the Massachusetts Opioid Recovery and Remediation Fund (ORRF), which resulted from the historic legal effort to demand justice from several private companies for the harms caused by the opioid epidemic. This is one of the first public-private partnerships of this magnitude using settlement funds for community-led initiatives.
Powered by RIZE in conjunction with the Commonwealth and guided by people with lived and living experience, Mosaic is creating a pathway for community-led initiatives that may not have been eligible for grant funding in the past to access settlement funds. This ensures the dollars are invested and remain in the communities most impacted by the opioid crisis.
Municipal Training & Technical Assistance In partnership with BSAS and municipalities receiving opioid abatement funds, RIZE manages the Municipal Training and Technical Assistance Program. This program aligns with Mosaic’s mission to ensure that opioid abatement funds are invested and remain in the communities most deeply impacted by the crisis while also fueling transformative change through grassroots, community-led efforts.
Mosaic’s programs support community-led initiatives that use ideas with promise to address the opioid overdose crisis. We are committed to ensuring that the dollars are invested and remain in the communities most deeply impacted by the crisis and in organizations that center the voices of people with lived and living experience.
RIZE Massachusetts Appoints Regional Coordinators to Support Effective Utilization of Opioid Settlement Funds RIZE Announces Grant Opportunity for Municipalities to Apply for Opioid Settlement Funds “Community-based organizations all across the Commonwealth work tirelessly each day to address the harms caused by the opioid epidemic, and Mosaic is an opportunity for us to invest in the amazing work they’re doing and help them bring that work to scale.
” – Dr. Kiame Mahaniah, Secretary of the Executive Office of Health and Human Services
Based on current listing details, eligibility includes: Community-based organizations and municipalities in Massachusetts. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Mosaic Opioid Recovery Municipal Matching Grant is a grant from RIZE Massachusetts Foundation that funds municipalities and their nonprofit partners to address the opioid crisis through matching grants. Funded by the Massachusetts Department of Public Health's Bureau of Substance Addiction Services, the Mosaic Opioid Recovery Partnership has awarded nearly $13 million across three rounds. In February 2025, nearly $1.5 million was distributed to 75 municipalities and partners. A second round of the Municipal Matching Grant program will be announced in February 2026. Eligible applicants are municipalities and nonprofit organizations in Massachusetts working on opioid recovery initiatives. Awards are up to $150,000.
Mosaic Community-Based Opioid Response Efforts (CORE) Grant Program is a grant from RIZE Massachusetts Foundation that funds community-led initiatives addressing the opioid epidemic in Massachusetts. Supported by opioid settlement funds managed through a public-private partnership with the MA Department of Public Health, the program awards $3.75 million over three years. Three-year grants range from $50,000 to $150,000 annually based on organizational size. Eligible applicants are Massachusetts nonprofits with annual operating budgets under $5 million that deliver prevention, harm reduction, treatment, or recovery services to historically underserved populations with high rates of opioid overdose deaths. Funds support general operating and capacity-building activities. Lobbying, capital campaigns, and individual support are not eligible uses.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.